Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Metabolix to Conduct Conference Call and Live Webcast of Investor Presentation on Yield10 Bioscience


Posted on: 17 Oct 16

WOBURN, Mass., Oct. 17, 2016 (GLOBE NEWSWIRE) -- Metabolix, Inc. (NASDAQ:MBLX), announced today that the Company will host a conference call and live webcast on Thursday, October 20 to provide an investor presentation on the mission, vision and technology platform of Yield10 Bioscience.  Metabolix recently announced that Yield10 is becoming its core business with a focus on developing disruptive technologies for step-change improvements to crop yield to enhance global food security.  

Metabolix invites shareholders to submit questions for consideration to IR@metabolix.com with the subject line: “Questions for Yield10 Call.” Questions submitted in advance of the call will be reviewed and certain of them may be addressed in management's prepared remarks or in the Q&A portion of the call.

Conference Call Information

Company management will host a conference call Thursday, October 20, 2016 at 4:30 p.m. (ET) to provide an investor presentation on Yield10 Bioscience. A live webcast of the call including the slide deck can be accessed through the Company’s website at http://www.metabolix.com in the investor relations section. To participate in the call, dial toll-free 877-709-8150 or 201-689-8354 (international).

To listen to a telephonic replay of the conference call, dial toll-free 877-660-6853 or 201-612-7415 (international) and enter pass code 13648035. The replay will be available for 14 days. In addition, the webcast will be archived on the Company’s website in the investor relations section.

About Metabolix 

Metabolix, Inc. is winding down its legacy PHA biopolymer business and becoming Yield10 Bioscience.  Yield10 is leveraging Metabolix’s extensive track record of innovation based around optimizing the flow of carbon intermediates in living systems with a focus on developing disruptive technologies for step-change improvements in crop yield. Yield10 is working on new approaches to improve fundamental elements of plant metabolism through enhanced photosynthetic efficiency and directed carbon utilization. Yield10 is advancing the development of several yield traits in crops such as camelina, canola, soybean and corn.  The Company is based in Woburn, MA.   

For more information, visit www.metabolix.com. (MBLX-E)

For more information on Yield10 Bioscience, visit Yield10.

GlobeNewswire
globenewswire.com

Last updated on: 18/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.